Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to compare the effects of nebulised salbutamol or ipratropium alone in patients with
COPD with those of combined salbutamol and ipratropium nebuliser solution on arterial oxygen
saturation (SaO2) and to characterise patients with COPD (chronic obstructive pulmonary
disease) at risk of significant arterial oxygen desaturation following nebulised salbutamol.